Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Feb;65(2):466–471. doi: 10.1128/iai.65.2.466-471.1997

Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads.

T Sawai 1, K Tomono 1, K Yanagihara 1, Y Yamamoto 1, M Kaku 1, Y Hirakata 1, H Koga 1, T Tashiro 1, S Kohno 1
PMCID: PMC174618  PMID: 9009298

Abstract

We describe a novel mouse model of acute staphylococcal pneumonia induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. For comparison, we also used various strains of bacteria, including three strains of S. aureus, two strains of Staphylococcus epidermidis, one strain of Streptococcus pyogenes, three strains of Pseudomonas aeruginosa, and one strain of Klebsiella pneumoniae. All except two strains of S. aureus were cleared rapidly from the lungs. When S. aureus NUMR1 enmeshed in agar beads was injected intravenously, the organisms concentrated and remained in the lung for a period longer than several weeks. Multiple lung abscesses were evident macroscopically, and histological examination of the infected lung showed multiple lung abscesses around the pulmonary arterioles, consisting of bacterial colonies encircled with fibrin filaments and surrounded by inflammatory cells of neutrophils and macrophages. When 14 strains of clinically isolated S. aureus were injected intravenously, the number of bacteria recovered from the lung tissue 7 days after infection correlated with the titer of staphylocoagulase (P < 0.01) but not with the titer of clumping factor. Injection of coagulase-deficient mutant strain DU5843 was associated with a markedly reduced number of viable bacteria isolated from the lung, compared with its coagulase-positive parental strain DU5789. Our results suggest that coagulase may play a role in the development of blood-borne staphylococcal pneumonia in our model. Our animal model is simple and reproducible and resembles blood-borne staphylococcal pneumonia in humans, and it could be useful for investigating the pathogenicity or treatment of staphylococcal pulmonary infection, including infections with methicillin-resistant S. aureus.

Full Text

The Full Text of this article is available as a PDF (979.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baddour L. M., Tayidi M. M., Walker E., McDevitt D., Foster T. J. Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis. J Med Microbiol. 1994 Oct;41(4):259–263. doi: 10.1099/00222615-41-4-259. [DOI] [PubMed] [Google Scholar]
  2. Cash H. A., Woods D. E., McCullough B., Johanson W. G., Jr, Bass J. A. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis. 1979 Mar;119(3):453–459. doi: 10.1164/arrd.1979.119.3.453. [DOI] [PubMed] [Google Scholar]
  3. Cawdery M., Foster W. D., Hawgood B. C., Taylor C. The role of coagulase in the defence of Staphylococcus aureus against phagocytosis. Br J Exp Pathol. 1969 Aug;50(4):408–412. [PMC free article] [PubMed] [Google Scholar]
  4. DeMaria T. F., Kapral F. A. Pulmonary infection of mice with Staphylococcus aureus. Infect Immun. 1978 Jul;21(1):114–123. doi: 10.1128/iai.21.1.114-123.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Esposito A. L., Pennington J. E. Effects of aging on antibacterial mechanisms in experimental pneumonia. Am Rev Respir Dis. 1983 Oct;128(4):662–667. doi: 10.1164/arrd.1983.128.4.662. [DOI] [PubMed] [Google Scholar]
  6. Esposito A. L., Quinn L. A., Lucey E. C., Snider G. L. Effect of the elastase inhibitor, eglin-c, on antibacterial mechanisms in experimental pneumonia. Description of a system to quantitate phagocytic and bactericidal activity of resident murine alveolar macrophages in vivo. Am Rev Respir Dis. 1987 Mar;135(3):676–681. doi: 10.1164/arrd.1987.135.3.676. [DOI] [PubMed] [Google Scholar]
  7. GREEN G. M., KASS E. H. THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG. J Exp Med. 1964 Jan 1;119:167–176. doi: 10.1084/jem.119.1.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goldstein E., Lippert W., Warshauer D. Pulmonary alveolar macrophage. Defender against bacterial infection of the lung. J Clin Invest. 1974 Sep;54(3):519–528. doi: 10.1172/JCI107788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gross G. N., Rehm S. R., Pierce A. K. The effect of complement depletion on lung clearance of bacteria. J Clin Invest. 1978 Aug;62(2):373–378. doi: 10.1172/JCI109138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Haraldsson I., Jonsson P. Histopathology and pathogenesis of mouse mastitis induced with Staphylococcus aureus mutants. J Comp Pathol. 1984 Apr;94(2):183–196. doi: 10.1016/0021-9975(84)90039-2. [DOI] [PubMed] [Google Scholar]
  11. Hasegawa N., San Clemente C. L. Virulence and immunity of Staphylococcus aureus BB and certain deficient mutants. Infect Immun. 1978 Nov;22(2):473–479. doi: 10.1128/iai.22.2.473-479.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hemker H. C., Bas B. M., Muller A. D. Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase. Biochim Biophys Acta. 1975 Jan 30;379(1):180–188. doi: 10.1016/0005-2795(75)90020-3. [DOI] [PubMed] [Google Scholar]
  13. Jonsson P., Lindberg M., Haraldsson I., Wadström T. Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect Immun. 1985 Sep;49(3):765–769. doi: 10.1128/iai.49.3.765-769.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jordens J. Z., Duckworth G. J., Williams R. J. Production of "virulence factors" by "epidemic" methicillin-resistant Staphylococcus aureus in vitro. J Med Microbiol. 1989 Dec;30(4):245–252. doi: 10.1099/00222615-30-4-245. [DOI] [PubMed] [Google Scholar]
  15. Kawabata S., Morita T., Iwanaga S., Igarashi H. Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin. J Biochem. 1985 Dec;98(6):1603–1614. doi: 10.1093/oxfordjournals.jbchem.a135430. [DOI] [PubMed] [Google Scholar]
  16. Louria D. B., Hensle T., Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967 Jul;67(1):1–22. doi: 10.7326/0003-4819-67-1-1. [DOI] [PubMed] [Google Scholar]
  17. Masuda S. An efficient method for the isolation of a mutant with an extremely low producibility of coagulase from a Staphylococcus aureus strain. Microbiol Immunol. 1983;27(9):801–805. doi: 10.1111/j.1348-0421.1983.tb00645.x. [DOI] [PubMed] [Google Scholar]
  18. McDevitt D., Vaudaux P., Foster T. J. Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect Immun. 1992 Apr;60(4):1514–1523. doi: 10.1128/iai.60.4.1514-1523.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Moreillon P., Entenza J. M., Francioli P., McDevitt D., Foster T. J., François P., Vaudaux P. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995 Dec;63(12):4738–4743. doi: 10.1128/iai.63.12.4738-4743.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Musher D. M., McKenzie S. O. Infections due to Staphylococcus aureus. Medicine (Baltimore) 1977 Sep;56(5):383–409. doi: 10.1097/00005792-197709000-00002. [DOI] [PubMed] [Google Scholar]
  21. Naraqi S., McDonnell G. Hematogenous staphylococcal pneumonia secondary to soft tissue infection. Chest. 1981 Feb;79(2):173–175. doi: 10.1378/chest.79.2.173. [DOI] [PubMed] [Google Scholar]
  22. Nugent K. M., Pesanti E. L. Nonphagocytic clearance of Staphylococcus aureus from murine lungs. Infect Immun. 1982 Jun;36(3):1185–1191. doi: 10.1128/iai.36.3.1185-1191.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nugent K. M., Pesanti E. L. Staphylococcal clearance and pulmonary macrophage function during influenza infection. Infect Immun. 1982 Dec;38(3):1256–1262. doi: 10.1128/iai.38.3.1256-1262.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Phonimdaeng P., O'Reilly M., Nowlan P., Bramley A. J., Foster T. J. The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol Microbiol. 1990 Mar;4(3):393–404. doi: 10.1111/j.1365-2958.1990.tb00606.x. [DOI] [PubMed] [Google Scholar]
  25. Seki K., Ogasawara M., Sakurada J., Murai M., Masuda S. Altered virulence of a pleiotropic Staphylococcus aureus mutant with a low producibility of coagulase and other factors in mice. Microbiol Immunol. 1989;33(12):981–990. doi: 10.1111/j.1348-0421.1989.tb03156.x. [DOI] [PubMed] [Google Scholar]
  26. Tuazon C. U., Sheagren J. N. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis. 1974 Jun;129(6):725–727. doi: 10.1093/infdis/129.6.725. [DOI] [PubMed] [Google Scholar]
  27. van der Vijver J. C., van Es-Boon M. M., Michel M. F. A study of virulence factors with induced mutants of Staphylococcus aureus. J Med Microbiol. 1975 May;8(2):279–287. doi: 10.1099/00222615-8-2-279. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES